SIT Pharma acquires MIZOLLEN® for France market
SIT Pharma is pleased to announce the acquisition of MIZOLLEN® from THERABEL HEALTHCARE LIMITED
Mizollen®
Mizollen® 10 Mg Mizolastine modified-release tablet Please refer to the Base de données publique des médicaments website for the updated Summary of Product Characteristics (SPC) and package insert (PIL).In compliance with legal requirements, it is not possible for us to provide any information concerning our drugs or infomation related to health issues, for which we encourage […]